Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Ethylenediamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylenediamine SCHEMBL9645942 | 0.89 | MEN1 (0.50) | MEN1KMT2ATSHR | |
| Ethylenediamine SCHEMBL8214212 | 0.85 | MEN1 (0.46) | MEN1KMT2ATSHR | |
| Ethylenediamine SCHEMBL8580116 | 0.85 | — | — | |
| Ethylenediamine SCHEMBL6286613 | 0.85 | MEN1 (0.46) | MEN1KMT2ATSHR | |
| Ethylenediamine SCHEMBL11443647 | 0.85 | MEN1 (0.46) | MEN1KMT2ATSHR | |
| Ethylenediamine SCHEMBL3746450 | 0.85 | MEN1 (0.46) | MEN1KMT2ATSHR | |
| Ethylenediamine SCHEMBL3613718 | 0.85 | MEN1 (0.46) | MEN1KMT2ATSHR | |
| Ethylenediamine SCHEMBL3746452 | 0.85 | MEN1 (0.46) | MEN1KMT2ATSHR | |
| Ethylenediamine SCHEMBL11236232 | 0.85 | — | — | |
| Ethylenediamine SCHEMBL11039278 | 0.85 | MEN1 (0.46) | MEN1KMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069173-A1 | ANALYTE SENSOR ELECTRODE ARRANGEMENTS | DEXCOM INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-12495996-B2 | Analyte sensor electrode arrangements | DEXCOM, INC. (US) | 2025-12-16 | — | — | US | disclosed |
| US-20230337947-A1 | ANALYTE SENSOR ELECTRODE ARRANGEMENTS | DEXCOM, INC. | 2023-10-26 | — | — | US | disclosed |
| US-11638543-B2 | Analyte sensor electrode arrangements | DEXCOM, INC. (US) | 2023-05-02 | — | — | US | disclosed |
| CN-115397797-A | Hydrogenation of L-sorbose | 巴斯夫欧洲公司 | 2022-11-25 | — | — | CN | disclosed |
| EP-3999655-A1 | ANALYTE SENSOR ELECTRODE ARRANGEMENTS | Dexcom, Inc. (US) | 2022-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069173-A1 | ANALYTE SENSOR ELECTRODE ARRANGEMENTS | SLC5A2, SLC5A1, CA2 | MEN1 810/4885KMT2A 3941/4885TSHR 2469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.